Nexviazyme

Made by

• Sanofi

Active Ingredient

Avalglucosidase alfa (genetical recombination)

Prospectus

Approval date

2021/9/27

Treats

• Glycogen storage disease type II, Pompe disease

Dosages

• ネクスビアザイム点滴静注用100mg -